Article

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer

2022-01-01

Abstract excerpt

The incidence and mortality of lung cancer rank top three of all cancers worldwide. Accounting for 85% of the total number of lung cancer, non-small cell lung cancer (NSCLC) is an important factor endangering human health. Re... | Find, read and cite all the research you need on Tech Science Press

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d54a0a42-7cba-5769-aff0-e641c30d52a9
DOI: 10.32604/oncologie.2022.027545

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung CancerDOI 10.32604/oncologie.2022.027545Read

Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance.Semantic proximity Read

Targeted therapy for non-small-cell lung cancer: past, present and future.Semantic proximity Read

NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.Semantic proximity Read

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read

Molecular Targets Beyond the Big 3.Semantic proximity Read

Current Landscape of Targeted Therapy in Lung Cancer.Semantic proximity Read

Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations.Semantic proximity Read

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read

Targeted Therapy for Non-Small Cell Lung Cancer.Semantic proximity Read

Sharpening the attack on non-small cell lung cancer.Semantic proximity Read

Treatment of Patients With Non-Small-Cell Lung Cancer Harboring Rare Oncogenic Mutations.Semantic proximity Read

Targeted Therapy and Immunotherapy Lead to Rapid Regression of Advanced Non-Small Cell Lung Cancer with Multiple Driver Mutations.Semantic proximity Read